Review of Toyoda K, et al. Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischemic stroke in Japan. Lancet Neurol. 2019 Jun;18(6):539-548

BACKGROUND: Prior meta-analyses showed that treatment with cilostazol, with or without aspirin, significantly reduced the incidence of recurrent ischemic stroke, occurrence of hemorrhagic stroke, and frequency of other serious vascular adverse events. METHODS: This review highlights the value of the...

Descripción completa

Detalles Bibliográficos

Autores principales:	Lo, Benjamin W. Y., Miyawaki, Satoru, Fukuda, Hitoshi, Koyanagi, Masaomi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Scientific Scholar 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193192/ https://www.ncbi.nlm.nih.gov/pubmed/32363048 http://dx.doi.org/10.25259/SNI_83_2020